The update covers devices used in procedures to implant the company’s Watchman heart device.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for ...

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

The bloc has now paused implementation three times, with the latest moratorium coming after reaching a framework deal with ...